vs

Side-by-side financial comparison of RXO, Inc. (RXO) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

Zimmer Biomet is the larger business by last-quarter revenue ($2.1B vs $1.5B, roughly 1.4× RXO, Inc.). Zimmer Biomet runs the higher net margin — 11.4% vs -3.1%, a 14.6% gap on every dollar of revenue. On growth, Zimmer Biomet posted the faster year-over-year revenue change (9.3% vs -11.9%). Zimmer Biomet produced more free cash flow last quarter ($245.9M vs $-9.0M). Over the past eight quarters, RXO, Inc.'s revenue compounded faster (26.8% CAGR vs 3.7%).

RXO, Inc. is a leading transportation and logistics solutions provider headquartered in the United States. Its core service portfolio includes freight brokerage, last-mile delivery for heavy and bulky goods, managed transportation services, and end-to-end supply chain optimization support, primarily catering to clients across the North American manufacturing, retail, and e-commerce segments.

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

RXO vs ZBH — Head-to-Head

Bigger by revenue
ZBH
ZBH
1.4× larger
ZBH
$2.1B
$1.5B
RXO
Growing faster (revenue YoY)
ZBH
ZBH
+21.2% gap
ZBH
9.3%
-11.9%
RXO
Higher net margin
ZBH
ZBH
14.6% more per $
ZBH
11.4%
-3.1%
RXO
More free cash flow
ZBH
ZBH
$254.9M more FCF
ZBH
$245.9M
$-9.0M
RXO
Faster 2-yr revenue CAGR
RXO
RXO
Annualised
RXO
26.8%
3.7%
ZBH

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
RXO
RXO
ZBH
ZBH
Revenue
$1.5B
$2.1B
Net Profit
$-46.0M
$238.3M
Gross Margin
64.6%
Operating Margin
-2.9%
17.9%
Net Margin
-3.1%
11.4%
Revenue YoY
-11.9%
9.3%
Net Profit YoY
-84.0%
30.5%
EPS (diluted)
$-0.28
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RXO
RXO
ZBH
ZBH
Q1 26
$2.1B
Q4 25
$1.5B
$2.2B
Q3 25
$1.4B
$2.0B
Q2 25
$1.4B
$2.1B
Q1 25
$1.4B
$1.9B
Q4 24
$1.7B
$2.0B
Q3 24
$1.0B
$1.8B
Q2 24
$930.0M
$1.9B
Net Profit
RXO
RXO
ZBH
ZBH
Q1 26
$238.3M
Q4 25
$-46.0M
$139.4M
Q3 25
$-14.0M
$230.9M
Q2 25
$-9.0M
$152.8M
Q1 25
$-31.0M
$182.0M
Q4 24
$-25.0M
$239.5M
Q3 24
$-243.0M
$249.1M
Q2 24
$-7.0M
$242.8M
Gross Margin
RXO
RXO
ZBH
ZBH
Q1 26
64.6%
Q4 25
64.7%
Q3 25
72.1%
Q2 25
71.5%
Q1 25
71.2%
Q4 24
71.0%
Q3 24
70.5%
Q2 24
71.5%
Operating Margin
RXO
RXO
ZBH
ZBH
Q1 26
17.9%
Q4 25
-2.9%
6.9%
Q3 25
-0.5%
17.6%
Q2 25
14.4%
Q1 25
-2.1%
15.3%
Q4 24
-1.4%
19.2%
Q3 24
-1.9%
15.3%
Q2 24
18.1%
Net Margin
RXO
RXO
ZBH
ZBH
Q1 26
11.4%
Q4 25
-3.1%
6.2%
Q3 25
-1.0%
11.5%
Q2 25
-0.6%
7.4%
Q1 25
-2.2%
9.5%
Q4 24
-1.5%
11.8%
Q3 24
-23.4%
13.7%
Q2 24
-0.8%
12.5%
EPS (diluted)
RXO
RXO
ZBH
ZBH
Q1 26
$1.22
Q4 25
$-0.28
$0.71
Q3 25
$-0.08
$1.16
Q2 25
$-0.05
$0.77
Q1 25
$-0.18
$0.91
Q4 24
$-0.17
$1.18
Q3 24
$-1.81
$1.23
Q2 24
$-0.06
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RXO
RXO
ZBH
ZBH
Cash + ST InvestmentsLiquidity on hand
$17.0M
$424.2M
Total DebtLower is stronger
$387.0M
$7.5B
Stockholders' EquityBook value
$1.5B
$12.7B
Total Assets
$3.3B
$22.7B
Debt / EquityLower = less leverage
0.25×
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RXO
RXO
ZBH
ZBH
Q1 26
$424.2M
Q4 25
$17.0M
$591.9M
Q3 25
$25.0M
$1.3B
Q2 25
$18.0M
$556.9M
Q1 25
$16.0M
$1.4B
Q4 24
$35.0M
$525.5M
Q3 24
$55.0M
$569.0M
Q2 24
$7.0M
$420.1M
Total Debt
RXO
RXO
ZBH
ZBH
Q1 26
$7.5B
Q4 25
$387.0M
Q3 25
$387.0M
Q2 25
$387.0M
Q1 25
$387.0M
Q4 24
$351.0M
Q3 24
$352.0M
Q2 24
$370.0M
Stockholders' Equity
RXO
RXO
ZBH
ZBH
Q1 26
$12.7B
Q4 25
$1.5B
$12.7B
Q3 25
$1.6B
$12.8B
Q2 25
$1.6B
$12.5B
Q1 25
$1.6B
$12.4B
Q4 24
$1.6B
$12.5B
Q3 24
$1.7B
$12.4B
Q2 24
$579.0M
$12.7B
Total Assets
RXO
RXO
ZBH
ZBH
Q1 26
$22.7B
Q4 25
$3.3B
$23.1B
Q3 25
$3.2B
$23.5B
Q2 25
$3.2B
$22.9B
Q1 25
$3.3B
$22.2B
Q4 24
$3.4B
$21.4B
Q3 24
$3.4B
$21.7B
Q2 24
$1.8B
$21.5B
Debt / Equity
RXO
RXO
ZBH
ZBH
Q1 26
0.59×
Q4 25
0.25×
Q3 25
0.24×
Q2 25
0.24×
Q1 25
0.24×
Q4 24
0.22×
Q3 24
0.21×
Q2 24
0.64×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RXO
RXO
ZBH
ZBH
Operating Cash FlowLast quarter
$7.0M
$359.4M
Free Cash FlowOCF − Capex
$-9.0M
$245.9M
FCF MarginFCF / Revenue
-0.6%
11.8%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$-8.0M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RXO
RXO
ZBH
ZBH
Q1 26
$359.4M
Q4 25
$7.0M
$517.4M
Q3 25
$23.0M
$418.7M
Q2 25
$23.0M
$378.2M
Q1 25
$-2.0M
$382.8M
Q4 24
$-7.0M
$506.3M
Q3 24
$-7.0M
$395.7M
Q2 24
$-5.0M
$369.4M
Free Cash Flow
RXO
RXO
ZBH
ZBH
Q1 26
$245.9M
Q4 25
$-9.0M
$442.6M
Q3 25
$9.0M
$363.7M
Q2 25
$9.0M
$328.1M
Q1 25
$-17.0M
$338.2M
Q4 24
$-19.0M
$454.8M
Q3 24
$-18.0M
$351.2M
Q2 24
$-16.0M
$316.7M
FCF Margin
RXO
RXO
ZBH
ZBH
Q1 26
11.8%
Q4 25
-0.6%
19.7%
Q3 25
0.6%
18.2%
Q2 25
0.6%
15.8%
Q1 25
-1.2%
17.7%
Q4 24
-1.1%
22.5%
Q3 24
-1.7%
19.3%
Q2 24
-1.7%
16.3%
Capex Intensity
RXO
RXO
ZBH
ZBH
Q1 26
Q4 25
1.1%
3.3%
Q3 25
1.0%
2.7%
Q2 25
1.0%
2.4%
Q1 25
1.0%
2.3%
Q4 24
0.7%
2.5%
Q3 24
1.1%
2.4%
Q2 24
1.2%
2.7%
Cash Conversion
RXO
RXO
ZBH
ZBH
Q1 26
1.51×
Q4 25
3.71×
Q3 25
1.81×
Q2 25
2.48×
Q1 25
2.10×
Q4 24
2.11×
Q3 24
1.59×
Q2 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RXO
RXO

Retail Sector$546.0M37%
Last Mile$298.0M20%
Food And Beverage Sector$225.0M15%
Other Sector$185.0M13%
Managed Transportation$133.0M9%
Automotive Sector$93.0M6%

ZBH
ZBH

Segment breakdown not available.

Related Comparisons